Abstract:Bacterial infections are common in the etiology of human diseases owing to the ubiquity of bacteria. Such infections promote the development of periodontal disease, bacterial pneumonia, typhoid, acute gastroenteritis, and diarrhea in susceptible hosts. These diseases may be resolved using antibiotics/antimicrobial therapy in some hosts. However, other hosts may be unable to eliminate the bacteria, allowing them to persist for long durations and significantly increasing the carrier's risk of developing cancer over time. Indeed, infectious pathogens are modifiable cancer risk factors, and through this comprehensive review, we highlight the complex relationship between bacterial infections and the development of several cancer types. For this review, searches were performed on the PubMed, Embase, and Web of Science databases encompassing the entirety of 2022. Based on our investigation, we found several critical associations, of which some are causative: Porphyromonas gingivalis and Fusobacterium nucleatum are associated with periodontal disease, Salmonella spp., Clostridium perfringens, Escherichia coli, Campylobacter spp., and Shigella are associated with gastroenteritis. Helicobacter pylori infection is implicated in the etiology of gastric cancer, and persistent Chlamydia infections present a risk factor for the development of cervical carcinoma, especially in patients with the human papillomavirus (HPV) coinfection. Salmonella typhi infections are linked with gallbladder cancer, and Chlamydia pneumoniae infection is implicated in lung cancer, etc. This knowledge helps identify the adaptation strategies used by bacteria to evade antibiotic/antimicrobial therapy. The article also sheds light on the role of antibiotics in cancer treatment, the consequences of their use, and strategies for limiting antibiotic resistance. Finally, the dual role of bacteria in cancer development as well as in cancer therapy is briefly discussed, as this is an area that may help to facilitate the development of novel microbe-based therapeutics as a means of securing improved outcomes.

Microbiome interactions: Acinetobacter baumannii biofilms as a co-factor in oral cancer progression

Oral Microbiota: A New Insight into Cancer Progression, Diagnosis and Treatment

Insights into the oral microbiota in human systemic cancers

Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria

Virulence Characteristics and Emerging Therapies for Biofilm-Forming Acinetobacter baumannii: A Review

Cancer invasion and anaerobic bacteria: new insights into mechanisms

The Roles and Interactions of Porphyromonas gingivalis and Fusobacterium nucleatum in Oral and Gastrointestinal Carcinogenesis: A Narrative Review

The Oral-Gut Microbiome Axis in Breast Cancer: from Basic Research to Therapeutic Applications

Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer

Oral Microbiota Associated with Oral and Gastroenteric Cancer

Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights

[The Oral Microbiome in the Development of Oral Cancer]

The emerging role of oral microbiota in oral cancer initiation, progression and stemness

An Overview of the Dichotomous Role of Microbiota in Cancer Progression and Management

Oral Microbiota and Tumor—A New Perspective of Tumor Pathogenesis

The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy

Understanding Microbial Dysbiosis as a Key Driver in Oral Squamous Cell Carcinoma Pathophysiology

Role of the microbiome in oral cancer occurrence, progression and therapy

Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers

Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients

Oral microbial dysbiosis in patients with oral cavity cancers